speb/financial-data huggingface dataset:
NICU.V cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
NICU.V balance_sheet (annual, 2025-12-31) — Cash Financial: 55899000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 55899000.00
NICU.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 85668000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 4430000.00
NICU.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -12206000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1479000.00
NICU.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -35098000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -10173000.00
NICU.V cash_flow (annual, 2025-12-31) — Changes In Cash: 38364000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -7222000.00
NICU.V balance_sheet (annual, 2025-12-31) — Common Stock: 141433000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 141433000.00
NICU.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: 98674000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 98674000.00
NICU.V cash_flow (annual, 2025-12-31) — Common Stock Issuance: 56831000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 2000.00
NICU.V income_statement (annual, 2025-12-31) — Cost Of Revenue: 67051000.00
NICU.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 22974000.00
NICU.V balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 16600000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 16600000.00
NICU.V balance_sheet (annual, 2025-12-31) — Current Assets: 88665000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 88665000.00
NICU.V balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 140000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 140000.00
NICU.V balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 140000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 140000.00
NICU.V balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 244000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 244000.00
NICU.V balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 10081000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 10081000.00
NICU.V balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 8136000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 8136000.00
NICU.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 28166000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 28166000.00
NICU.V cash_flow (annual, 2025-12-31) — Deferred Income Tax: -5898000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -1291000.00
NICU.V cash_flow (annual, 2025-12-31) — Deferred Tax: -5898000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Deferred Tax: -1291000.00
NICU.V cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 11536000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 4186000.00
NICU.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 215042407.00
NICU.V income_statement (annual, 2025-12-31) — Diluted EPS: -0.08
NICU.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -16983000.00
NICU.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -25938000.00
NICU.V income_statement (annual, 2025-12-31) — EBIT: -16696000.00
NICU.V income_statement (quarterly, 2025-12-31) — EBIT: -23609000.00
NICU.V income_statement (annual, 2025-12-31) — EBITDA: -5160000.00
NICU.V income_statement (quarterly, 2025-12-31) — EBITDA: -19423000.00
NICU.V cash_flow (annual, 2025-12-31) — End Cash Position: 55899000.00
NICU.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 55899000.00
NICU.V balance_sheet (annual, 2025-12-31) — Financial Assets: 916000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Financial Assets: 916000.00
NICU.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: 85668000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 4430000.00
NICU.V cash_flow (annual, 2025-12-31) — Free Cash Flow: -42896000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -11656000.00
NICU.V cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -807000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -395000.00
NICU.V cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -394000.00
NICU.V income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 0.00
NICU.V income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 70000.00
NICU.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -71000.00
NICU.V income_statement (annual, 2025-12-31) — General And Administrative Expense: 12425000.00
NICU.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 3843000.00
NICU.V balance_sheet (annual, 2025-12-31) — Gross PPE: 115048000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 115048000.00
NICU.V income_statement (annual, 2025-12-31) — Gross Profit: -2081000.00
NICU.V income_statement (quarterly, 2025-12-31) — Gross Profit: 2795000.00
NICU.V income_statement (annual, 2025-12-31) — Interest Expense: 6175000.00
NICU.V income_statement (quarterly, 2025-12-31) — Interest Expense: 3618000.00
NICU.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 6175000.00
NICU.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3618000.00
NICU.V cash_flow (annual, 2025-12-31) — Interest Paid Cff: -2446000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -718000.00
NICU.V balance_sheet (annual, 2025-12-31) — Inventory: 4987000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Inventory: 4987000.00
NICU.V balance_sheet (annual, 2025-12-31) — Invested Capital: 114356000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 114356000.00
NICU.V cash_flow (annual, 2025-12-31) — Investing Cash Flow: -12206000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1479000.00
NICU.V cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 56831000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 2000.00
NICU.V cash_flow (annual, 2025-12-31) — Issuance Of Debt: 22638000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 303000.00
NICU.V balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 76000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 76000.00
NICU.V balance_sheet (annual, 2025-12-31) — Long Term Debt: 15682000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 15682000.00
NICU.V balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 15758000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 15758000.00
NICU.V cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 22638000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 303000.00
NICU.V balance_sheet (annual, 2025-12-31) — Long Term Provisions: 14655000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 14655000.00
NICU.V cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 56831000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 2000.00
NICU.V income_statement (annual, 2025-12-31) — Net Income: -16983000.00
NICU.V income_statement (quarterly, 2025-12-31) — Net Income: -25938000.00
NICU.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -16983000.00
NICU.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -25938000.00
NICU.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -16983000.00
NICU.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -25938000.00
NICU.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -16983000.00
NICU.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -25938000.00
NICU.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -16983000.00
NICU.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -25938000.00
NICU.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -16983000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -25938000.00
NICU.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -16983000.00
NICU.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -25938000.00
NICU.V income_statement (annual, 2025-12-31) — Net Interest Income: -7201000.00
NICU.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -3971000.00
NICU.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 22638000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 337000.00
NICU.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 22638000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 337000.00
NICU.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -7201000.00
NICU.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3971000.00
NICU.V cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2309000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1241000.00
NICU.V cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -4408000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 4000.00
NICU.V balance_sheet (annual, 2025-12-31) — Net PPE: 103311000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 103311000.00
NICU.V cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -7798000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1483000.00
NICU.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 98674000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 98674000.00
NICU.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 29764000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 29764000.00
NICU.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 21356000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 21356000.00
NICU.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 8408000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 8408000.00
NICU.V income_statement (annual, 2025-12-31) — Normalized EBITDA: -22045000.00
NICU.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2227000.00
NICU.V income_statement (annual, 2025-12-31) — Normalized Income: -29521059.33
NICU.V income_statement (quarterly, 2025-12-31) — Normalized Income: -9556105.26
NICU.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: -35098000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -10173000.00
NICU.V cash_flow (annual, 2025-12-31) — Operating Gains Losses: -1201000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -789000.00
NICU.V income_statement (annual, 2025-12-31) — Operating Income: -33215000.00
NICU.V income_statement (quarterly, 2025-12-31) — Operating Income: -6342000.00
NICU.V income_statement (annual, 2025-12-31) — Operating Revenue: 60016000.00
NICU.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 20815000.00
NICU.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 249858803.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 249858803.00
NICU.V balance_sheet (annual, 2025-12-31) — Other Equity Interest: 7977000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 7977000.00
NICU.V income_statement (annual, 2025-12-31) — Other Gand A: 8360000.00
NICU.V income_statement (quarterly, 2025-12-31) — Other Gand A: 2054000.00
NICU.V income_statement (annual, 2025-12-31) — Other Income Expense: 17545000.00
NICU.V income_statement (quarterly, 2025-12-31) — Other Income Expense: -16914000.00
NICU.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: -26617000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 8888000.00
NICU.V balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1032000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1032000.00
NICU.V balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 6907000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 6907000.00
NICU.V income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 660000.00
NICU.V income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 282000.00
NICU.V income_statement (annual, 2025-12-31) — Other Operating Expenses: 8221000.00
NICU.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 2310000.00
NICU.V balance_sheet (annual, 2025-12-31) — Other Receivables: 3943000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Other Receivables: 3943000.00
NICU.V balance_sheet (annual, 2025-12-31) — Payables: 1345000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Payables: 1345000.00
NICU.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 17945000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 17945000.00
NICU.V balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1054000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1054000.00
NICU.V income_statement (annual, 2025-12-31) — Pretax Income: -22871000.00
NICU.V income_statement (quarterly, 2025-12-31) — Pretax Income: -27227000.00
NICU.V cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 10954000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 6050000.00
NICU.V cash_flow (annual, 2025-12-31) — Purchase Of PPE: -7798000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1483000.00
NICU.V balance_sheet (annual, 2025-12-31) — Raw Materials: 4987000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Raw Materials: 4987000.00
NICU.V balance_sheet (annual, 2025-12-31) — Receivables: 26481000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Receivables: 26481000.00
NICU.V income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 67051000.00
NICU.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 22974000.00
NICU.V income_statement (annual, 2025-12-31) — Reconciled Depreciation: 11536000.00
NICU.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 4186000.00
NICU.V income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: -16815000.00
NICU.V income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 17125000.00
NICU.V balance_sheet (annual, 2025-12-31) — Retained Earnings: -58599000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -58599000.00
NICU.V income_statement (annual, 2025-12-31) — Salaries And Wages: 4065000.00
NICU.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 1789000.00
NICU.V cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
NICU.V income_statement (annual, 2025-12-31) — Selling General And Administration: 12425000.00
NICU.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 3843000.00
NICU.V balance_sheet (annual, 2025-12-31) — Share Issued: 249858803.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 249858803.00
NICU.V income_statement (annual, 2025-12-31) — Special Income Charges: 16815000.00
NICU.V income_statement (quarterly, 2025-12-31) — Special Income Charges: -17125000.00
NICU.V cash_flow (annual, 2025-12-31) — Stock Based Compensation: 4065000.00
NICU.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1789000.00
NICU.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: 98674000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 98674000.00
NICU.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: 98674000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 98674000.00
NICU.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 4346940.67
NICU.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -814105.26
NICU.V income_statement (annual, 2025-12-31) — Tax Provision: -5888000.00
NICU.V income_statement (quarterly, 2025-12-31) — Tax Provision: -1289000.00
NICU.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.26
NICU.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.05
NICU.V balance_sheet (annual, 2025-12-31) — Taxes Receivable: 860000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 860000.00
NICU.V balance_sheet (annual, 2025-12-31) — Total Assets: 193924000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 193924000.00
NICU.V balance_sheet (annual, 2025-12-31) — Total Capitalization: 114356000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 114356000.00
NICU.V balance_sheet (annual, 2025-12-31) — Total Debt: 15898000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 15898000.00
NICU.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 98674000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 98674000.00
NICU.V income_statement (annual, 2025-12-31) — Total Expenses: 98185000.00
NICU.V income_statement (quarterly, 2025-12-31) — Total Expenses: 32111000.00
NICU.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 95250000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 95250000.00
NICU.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 105259000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 105259000.00
NICU.V balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 67084000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 67084000.00
NICU.V income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -33220000.00
NICU.V income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -6539000.00
NICU.V income_statement (annual, 2025-12-31) — Total Other Finance Cost: 1026000.00
NICU.V income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 353000.00
NICU.V income_statement (annual, 2025-12-31) — Total Unusual Items: 16885000.00
NICU.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: -17196000.00
NICU.V income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 16885000.00
NICU.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -17196000.00
NICU.V balance_sheet (annual, 2025-12-31) — Working Capital: 60499000.00
NICU.V balance_sheet (quarterly, 2025-12-31) — Working Capital: 60499000.00
NICU.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 9914000.00
NICU.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 25913000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3383000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 28208000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -15747000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 8958000.00
NICU.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 249931519.00
NICU.V income_statement (quarterly, 2026-03-31) — Basic EPS: -0.03
NICU.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 55899000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2555000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 176000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 141753000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 35770000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 35770000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: 0.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Cash Financial: 35770000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -648000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -3322000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -16159000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -4992000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 266000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Change In Inventory: -278000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Change In Payable: -4726000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -4726000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 32000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Change In Receivables: -10164000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 266000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -15136000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -10164000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: -20129000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 141753000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 93662000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
NICU.V income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 20596000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 9718000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 78702000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 111000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 111000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 0.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 11498000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 9539000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 24976000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -359000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Deferred Tax: -359000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Depletion: 1107000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Depreciation: 2918000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 4025000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 2918000.00
NICU.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 249931519.00
NICU.V income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.03
NICU.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -6161000.00
NICU.V income_statement (quarterly, 2026-03-31) — EBIT: -4647000.00
NICU.V income_statement (quarterly, 2026-03-31) — EBITDA: -622000.00
NICU.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 35770000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Financial Assets: 533000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -648000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -18714000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 383000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 40000.00
NICU.V income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 40000.00
NICU.V income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -20000.00
NICU.V income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 3072000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Gross PPE: 118315000.00
NICU.V income_statement (quarterly, 2026-03-31) — Gross Profit: 5317000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 266000.00
NICU.V income_statement (quarterly, 2026-03-31) — Interest Expense: 1873000.00
NICU.V income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1873000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -660000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Inventory: 5265000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: 109767000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -3322000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
NICU.V cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 65000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 16105000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 16170000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
NICU.V cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -43000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 14779000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 56023000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
NICU.V income_statement (quarterly, 2026-03-31) — Net Income: -6161000.00
NICU.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -6161000.00
NICU.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -6161000.00
NICU.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -6161000.00
NICU.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -6161000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -6427000.00
NICU.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -6161000.00
NICU.V income_statement (quarterly, 2026-03-31) — Net Interest Income: -2117000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -43000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -43000.00
NICU.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2117000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -767000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Net PPE: 102568000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -2555000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 93662000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 26282000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 18233000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 8049000.00
NICU.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -583000.00
NICU.V income_statement (quarterly, 2026-03-31) — Normalized Income: -6124147.39
NICU.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -16159000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 423000.00
NICU.V income_statement (quarterly, 2026-03-31) — Operating Income: -4597000.00
NICU.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 25913000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 250254385.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 7977000.00
NICU.V income_statement (quarterly, 2026-03-31) — Other Gand A: 1712000.00
NICU.V income_statement (quarterly, 2026-03-31) — Other Income Expense: 194000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -45000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1032000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 6966000.00
NICU.V income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 233000.00
NICU.V income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 2970000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Other Properties: 384000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Other Receivables: 8025000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Payables: 3649000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 13367000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1022000.00
NICU.V income_statement (quarterly, 2026-03-31) — Pretax Income: -6520000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 55000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -2555000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Receivables: 36645000.00
NICU.V income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 20596000.00
NICU.V income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 4025000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -43000.00
NICU.V income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 59000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -65026000.00
NICU.V income_statement (quarterly, 2026-03-31) — Salaries And Wages: 1360000.00
NICU.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3072000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 250254385.00
NICU.V income_statement (quarterly, 2026-03-31) — Special Income Charges: -19000.00
NICU.V cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1360000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 93662000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 93662000.00
NICU.V income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -2147.39
NICU.V income_statement (quarterly, 2026-03-31) — Tax Provision: -359000.00
NICU.V income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.06
NICU.V balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 412000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Total Assets: 182835000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 109767000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Total Debt: 16281000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 93662000.00
NICU.V income_statement (quarterly, 2026-03-31) — Total Expenses: 30510000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 89173000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 104133000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 64197000.00
NICU.V income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -4473000.00
NICU.V income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 244000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 266000.00
NICU.V income_statement (quarterly, 2026-03-31) — Total Unusual Items: -39000.00
NICU.V income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -39000.00
NICU.V balance_sheet (quarterly, 2026-03-31) — Working Capital: 53726000.00
NIE income_statement (annual, 2022-01-31) — Basic Average Shares: 27808582.00
NIE income_statement (annual, 2022-01-31) — Basic EPS: 2.68
NIE income_statement (annual, 2022-01-31) — Diluted Average Shares: 27808582.00
NIE income_statement (annual, 2022-01-31) — Diluted EPS: 2.68
NIE balance_sheet (annual, 2022-01-31) — Preferred Securities Outside Stock Equity: 0.00
NIE income_statement (annual, 2023-01-31) — +Operating Expense: 497000.00
NIE income_statement (annual, 2023-01-31) — +Total Revenue: -107931000.00
NIE balance_sheet (annual, 2023-01-31) — Accounts Payable: 3238000.00
NIE balance_sheet (annual, 2023-01-31) — Additional Paid In Capital: 670598000.00
NIE income_statement (annual, 2023-01-31) — Basic Average Shares: 27730946.00
NIE income_statement (annual, 2023-01-31) — Basic EPS: -3.91
NIE balance_sheet (annual, 2023-01-31) — Capital Stock: 0.00
NIE balance_sheet (annual, 2023-01-31) — Cash And Cash Equivalents: 101000.00
NIE balance_sheet (annual, 2023-01-31) — Cash Cash Equivalents And Federal Funds Sold: 198000.00
NIE balance_sheet (annual, 2023-01-31) — Cash Financial: 101000.00
NIE balance_sheet (annual, 2023-01-31) — Common Stock: 0.00
NIE balance_sheet (annual, 2023-01-31) — Common Stock Equity: 621644000.00
NIE balance_sheet (annual, 2023-01-31) — Derivative Product Liabilities: 22000.00
NIE income_statement (annual, 2023-01-31) — Diluted Average Shares: 27730946.00
NIE income_statement (annual, 2023-01-31) — Diluted EPS: -3.91
NIE income_statement (annual, 2023-01-31) — Diluted NI Availto Com Stockholders: -108428000.00
NIE balance_sheet (annual, 2023-01-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 619316000.00
NIE income_statement (annual, 2023-01-31) — Gain On Sale Of Security: 5373000.00
NIE income_statement (annual, 2023-01-31) — General And Administrative Expense: 1267000.00
NIE income_statement (annual, 2023-01-31) — Interest Expense: 0.00
NIE income_statement (annual, 2023-01-31) — Interest Income: 2391000.00
NIE balance_sheet (annual, 2023-01-31) — Investmentin Financial Assets: 619316000.00
NIE balance_sheet (annual, 2023-01-31) — Investments And Advances: 619316000.00
NIE income_statement (annual, 2023-01-31) — Net Income: -108428000.00
NIE income_statement (annual, 2023-01-31) — Net Income Common Stockholders: -108428000.00
NIE income_statement (annual, 2023-01-31) — Net Income Continuous Operations: -108428000.00
NIE income_statement (annual, 2023-01-31) — Net Income From Continuing And Discontinued Operation: -108428000.00
NIE income_statement (annual, 2023-01-31) — Net Income From Continuing Operation Net Minority Interest: -108428000.00
NIE income_statement (annual, 2023-01-31) — Net Income Including Noncontrolling Interests: -108428000.00
NIE income_statement (annual, 2023-01-31) — Net Interest Income: 2391000.00
NIE balance_sheet (annual, 2023-01-31) — Net Tangible Assets: 621644000.00
NIE income_statement (annual, 2023-01-31) — Normalized Income: -108428000.00
NIE income_statement (annual, 2023-01-31) — Operating Revenue: -107931000.00
NIE balance_sheet (annual, 2023-01-31) — Ordinary Shares Number: 27708965.00
NIE income_statement (annual, 2023-01-31) — Other Operating Expenses: -770000.00
NIE balance_sheet (annual, 2023-01-31) — Other Payable: 719000.00
NIE balance_sheet (annual, 2023-01-31) — Payables: 3957000.00
NIE balance_sheet (annual, 2023-01-31) — Preferred Securities Outside Stock Equity: 0.00
NIE balance_sheet (annual, 2023-01-31) — Prepaid Assets: 27000.00
NIE income_statement (annual, 2023-01-31) — Pretax Income: -108428000.00
NIE balance_sheet (annual, 2023-01-31) — Receivables: 6015000.00
NIE balance_sheet (annual, 2023-01-31) — Retained Earnings: -48954000.00
NIE income_statement (annual, 2023-01-31) — Selling General And Administration: 1267000.00
NIE balance_sheet (annual, 2023-01-31) — Share Issued: 27708965.00
NIE balance_sheet (annual, 2023-01-31) — Stockholders Equity: 621644000.00
NIE balance_sheet (annual, 2023-01-31) — Tangible Book Value: 621644000.00
NIE income_statement (annual, 2023-01-31) — Tax Effect Of Unusual Items: 0.00
NIE income_statement (annual, 2023-01-31) — Tax Rate For Calcs: 0.00
NIE balance_sheet (annual, 2023-01-31) — Taxes Receivable: 0.00
NIE balance_sheet (annual, 2023-01-31) — Total Assets: 625690000.00
NIE balance_sheet (annual, 2023-01-31) — Total Equity Gross Minority Interest: 621644000.00
NIE balance_sheet (annual, 2023-01-31) — Total Liabilities Net Minority Interest: 4046000.00
NIE income_statement (annual, 2024-01-31) — +Operating Expense: 450000.00
NIE income_statement (annual, 2024-01-31) — +Total Revenue: 94201000.00
NIE balance_sheet (annual, 2024-01-31) — Accounts Payable: 10921000.00
NIE balance_sheet (annual, 2024-01-31) — Additional Paid In Capital: 645892000.00
NIE balance_sheet (annual, 2024-01-31) — Available For Sale Securities: 6235000.00
NIE income_statement (annual, 2024-01-31) — Basic Average Shares: 27655162.00
NIE income_statement (annual, 2024-01-31) — Basic EPS: 3.39
NIE balance_sheet (annual, 2024-01-31) — Capital Stock: 0.00
NIE balance_sheet (annual, 2024-01-31) — Cash And Cash Equivalents: 20380000.00
NIE balance_sheet (annual, 2024-01-31) — Cash Cash Equivalents And Federal Funds Sold: 20462000.00
NIE balance_sheet (annual, 2024-01-31) — Cash Financial: 20380000.00
NIE balance_sheet (annual, 2024-01-31) — Common Stock: 0.00
NIE balance_sheet (annual, 2024-01-31) — Common Stock Equity: 659977000.00
NIE balance_sheet (annual, 2024-01-31) — Derivative Product Liabilities: 116000.00
NIE income_statement (annual, 2024-01-31) — Diluted Average Shares: 27655162.00
NIE income_statement (annual, 2024-01-31) — Diluted EPS: 3.39
NIE income_statement (annual, 2024-01-31) — Diluted NI Availto Com Stockholders: 93751000.00
NIE balance_sheet (annual, 2024-01-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 637709000.00
NIE income_statement (annual, 2024-01-31) — Gain On Sale Of Security: 15791000.00
NIE income_statement (annual, 2024-01-31) — General And Administrative Expense: 1041000.00
NIE income_statement (annual, 2024-01-31) — Interest Expense: 0.00
NIE income_statement (annual, 2024-01-31) — Interest Income: 4568000.00
NIE balance_sheet (annual, 2024-01-31) — Investmentin Financial Assets: 643944000.00
NIE balance_sheet (annual, 2024-01-31) — Investments And Advances: 643944000.00
NIE income_statement (annual, 2024-01-31) — Net Income: 93751000.00
NIE income_statement (annual, 2024-01-31) — Net Income Common Stockholders: 93751000.00
NIE income_statement (annual, 2024-01-31) — Net Income Continuous Operations: 93751000.00
NIE income_statement (annual, 2024-01-31) — Net Income From Continuing And Discontinued Operation: 93751000.00
NIE income_statement (annual, 2024-01-31) — Net Income From Continuing Operation Net Minority Interest: 93751000.00
NIE income_statement (annual, 2024-01-31) — Net Income Including Noncontrolling Interests: 93751000.00
NIE income_statement (annual, 2024-01-31) — Net Interest Income: 4568000.00
NIE balance_sheet (annual, 2024-01-31) — Net Tangible Assets: 659977000.00
NIE income_statement (annual, 2024-01-31) — Normalized Income: 93751000.00
NIE income_statement (annual, 2024-01-31) — Operating Revenue: 94201000.00
NIE balance_sheet (annual, 2024-01-31) — Ordinary Shares Number: 27708965.00
NIE income_statement (annual, 2024-01-31) — Other Operating Expenses: -591000.00
NIE balance_sheet (annual, 2024-01-31) — Other Payable: 771000.00
NIE balance_sheet (annual, 2024-01-31) — Payables: 11692000.00
NIE balance_sheet (annual, 2024-01-31) — Preferred Securities Outside Stock Equity: 0.00
NIE balance_sheet (annual, 2024-01-31) — Prepaid Assets: 16000.00
NIE income_statement (annual, 2024-01-31) — Pretax Income: 93751000.00
NIE balance_sheet (annual, 2024-01-31) — Receivables: 7269000.00
NIE balance_sheet (annual, 2024-01-31) — Retained Earnings: 14085000.00
NIE income_statement (annual, 2024-01-31) — Selling General And Administration: 1041000.00
NIE balance_sheet (annual, 2024-01-31) — Share Issued: 27708965.00
NIE balance_sheet (annual, 2024-01-31) — Stockholders Equity: 659977000.00
NIE balance_sheet (annual, 2024-01-31) — Tangible Book Value: 659977000.00
NIE income_statement (annual, 2024-01-31) — Tax Effect Of Unusual Items: 0.00
NIE income_statement (annual, 2024-01-31) — Tax Rate For Calcs: 0.21
NIE balance_sheet (annual, 2024-01-31) — Taxes Receivable: 0.00
NIE balance_sheet (annual, 2024-01-31) — Total Assets: 671835000.00
NIE balance_sheet (annual, 2024-01-31) — Total Equity Gross Minority Interest: 659977000.00
NIE balance_sheet (annual, 2024-01-31) — Total Liabilities Net Minority Interest: 11858000.00
NIE income_statement (annual, 2025-01-31) — +Operating Expense: 512000.00
NIE income_statement (annual, 2025-01-31) — +Total Revenue: 130832000.00
NIE balance_sheet (annual, 2025-01-31) — Accounts Payable: 2600000.00
NIE balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 2600000.00
NIE balance_sheet (annual, 2025-01-31) — Additional Paid In Capital: 645892000.00
NIE balance_sheet (quarterly, 2025-01-31) — Additional Paid In Capital: 645892000.00
NIE balance_sheet (annual, 2025-01-31) — Available For Sale Securities: 23961000.00
NIE balance_sheet (quarterly, 2025-01-31) — Available For Sale Securities: 23961000.00
NIE balance_sheet (annual, 2025-01-31) — Capital Stock: 0.00
NIE balance_sheet (quarterly, 2025-01-31) — Capital Stock: 0.00
NIE balance_sheet (annual, 2025-01-31) — Cash And Cash Equivalents: 20255000.00
NIE balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 20255000.00
NIE balance_sheet (annual, 2025-01-31) — Cash Cash Equivalents And Federal Funds Sold: 20338000.00
NIE balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Federal Funds Sold: 20338000.00
NIE balance_sheet (annual, 2025-01-31) — Cash Financial: 20255000.00
NIE balance_sheet (quarterly, 2025-01-31) — Cash Financial: 20255000.00
NIE balance_sheet (annual, 2025-01-31) — Common Stock: 0.00
NIE balance_sheet (quarterly, 2025-01-31) — Common Stock: 0.00
NIE balance_sheet (annual, 2025-01-31) — Common Stock Equity: 734879000.00
NIE balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: 734879000.00
NIE balance_sheet (annual, 2025-01-31) — Derivative Product Liabilities: 103000.00
NIE balance_sheet (quarterly, 2025-01-31) — Derivative Product Liabilities: 103000.00
NIE income_statement (annual, 2025-01-31) — Diluted NI Availto Com Stockholders: 130320000.00
NIE balance_sheet (annual, 2025-01-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 691746000.00
NIE balance_sheet (quarterly, 2025-01-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 691746000.00
NIE income_statement (annual, 2025-01-31) — Gain On Sale Of Security: 80864000.00
NIE income_statement (annual, 2025-01-31) — General And Administrative Expense: 1089000.00
NIE income_statement (annual, 2025-01-31) — Interest Expense: 0.00
NIE income_statement (annual, 2025-01-31) — Interest Income: 4887000.00
NIE balance_sheet (annual, 2025-01-31) — Investmentin Financial Assets: 715707000.00
NIE balance_sheet (quarterly, 2025-01-31) — Investmentin Financial Assets: 715707000.00
NIE balance_sheet (annual, 2025-01-31) — Investments And Advances: 715707000.00
NIE balance_sheet (quarterly, 2025-01-31) — Investments And Advances: 715707000.00
NIE income_statement (annual, 2025-01-31) — Net Income: 130320000.00
NIE income_statement (annual, 2025-01-31) — Net Income Common Stockholders: 130320000.00
NIE income_statement (annual, 2025-01-31) — Net Income Continuous Operations: 130320000.00
NIE income_statement (annual, 2025-01-31) — Net Income From Continuing And Discontinued Operation: 130320000.00
NIE income_statement (annual, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: 130320000.00
NIE income_statement (annual, 2025-01-31) — Net Income Including Noncontrolling Interests: 130320000.00
NIE income_statement (annual, 2025-01-31) — Net Interest Income: 4887000.00
NIE balance_sheet (annual, 2025-01-31) — Net Tangible Assets: 734879000.00
NIE balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 734879000.00
NIE income_statement (annual, 2025-01-31) — Normalized Income: 130320000.00
NIE income_statement (annual, 2025-01-31) — Operating Revenue: 130832000.00
NIE balance_sheet (annual, 2025-01-31) — Ordinary Shares Number: 27708965.00
NIE balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 27708965.00
NIE income_statement (annual, 2025-01-31) — Other Operating Expenses: -577000.00
NIE balance_sheet (annual, 2025-01-31) — Other Payable: 823000.00
NIE balance_sheet (quarterly, 2025-01-31) — Other Payable: 823000.00
NIE balance_sheet (annual, 2025-01-31) — Payables: 3423000.00
NIE balance_sheet (quarterly, 2025-01-31) — Payables: 3423000.00
NIE balance_sheet (annual, 2025-01-31) — Preferred Securities Outside Stock Equity: 0.00
NIE balance_sheet (quarterly, 2025-01-31) — Preferred Securities Outside Stock Equity: 0.00
NIE balance_sheet (annual, 2025-01-31) — Prepaid Assets: 16000.00
NIE balance_sheet (quarterly, 2025-01-31) — Prepaid Assets: 16000.00
NIE income_statement (annual, 2025-01-31) — Pretax Income: 130320000.00
NIE balance_sheet (annual, 2025-01-31) — Receivables: 2245000.00
NIE balance_sheet (quarterly, 2025-01-31) — Receivables: 2245000.00
NIE balance_sheet (annual, 2025-01-31) — Retained Earnings: 88987000.00
NIE balance_sheet (quarterly, 2025-01-31) — Retained Earnings: 88987000.00
NIE income_statement (annual, 2025-01-31) — Selling General And Administration: 1089000.00
NIE balance_sheet (annual, 2025-01-31) — Share Issued: 27708965.00
NIE balance_sheet (quarterly, 2025-01-31) — Share Issued: 27708965.00
NIE balance_sheet (annual, 2025-01-31) — Stockholders Equity: 734879000.00
NIE balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 734879000.00
NIE balance_sheet (annual, 2025-01-31) — Tangible Book Value: 734879000.00
NIE balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 734879000.00
NIE income_statement (annual, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
NIE income_statement (annual, 2025-01-31) — Tax Rate For Calcs: 0.21
NIE balance_sheet (annual, 2025-01-31) — Taxes Receivable: 0.00
NIE balance_sheet (quarterly, 2025-01-31) — Taxes Receivable: 0.00
NIE balance_sheet (annual, 2025-01-31) — Total Assets: 738453000.00
NIE balance_sheet (quarterly, 2025-01-31) — Total Assets: 738453000.00
NIE balance_sheet (annual, 2025-01-31) — Total Equity Gross Minority Interest: 734879000.00
NIE balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 734879000.00
NIE balance_sheet (annual, 2025-01-31) — Total Liabilities Net Minority Interest: 3574000.00
NIE balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 3574000.00
NIE income_statement (annual, 2026-01-31) — +Operating Expense: 514000.00
NIE income_statement (annual, 2026-01-31) — +Total Revenue: 114848000.00
NIE balance_sheet (annual, 2026-01-31) — Accounts Payable: 2956000.00
NIE balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 2956000.00
NIE balance_sheet (annual, 2026-01-31) — Additional Paid In Capital: 645892000.00
NIE balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 645892000.00
NIE balance_sheet (annual, 2026-01-31) — Available For Sale Securities: 26794000.00
NIE balance_sheet (quarterly, 2026-01-31) — Available For Sale Securities: 26794000.00
NIE balance_sheet (annual, 2026-01-31) — Capital Stock: 0.00
NIE balance_sheet (quarterly, 2026-01-31) — Capital Stock: 0.00
NIE balance_sheet (annual, 2026-01-31) — Cash And Cash Equivalents: 20060000.00
NIE balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 20060000.00
NIE balance_sheet (annual, 2026-01-31) — Cash Cash Equivalents And Federal Funds Sold: 20164000.00
NIE balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Federal Funds Sold: 20164000.00
NIE balance_sheet (annual, 2026-01-31) — Cash Financial: 20060000.00
NIE balance_sheet (quarterly, 2026-01-31) — Cash Financial: 20060000.00
NIE balance_sheet (annual, 2026-01-31) — Common Stock: 0.00
NIE balance_sheet (quarterly, 2026-01-31) — Common Stock: 0.00
NIE balance_sheet (annual, 2026-01-31) — Common Stock Equity: 779220000.00
NIE balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 779220000.00
NIE balance_sheet (annual, 2026-01-31) — Derivative Product Liabilities: 122000.00
NIE balance_sheet (quarterly, 2026-01-31) — Derivative Product Liabilities: 122000.00
NIE income_statement (annual, 2026-01-31) — Diluted Average Shares: 27683777.00